NLS Pharmaceutics falls after cutting 50% of workforce

NewcelX AG

16/11/2023 16:10

** U.S.-listed shares of Swiss drug developer NLS
Pharmaceutics  NLSP.O  fall ~34.5% to 31 cents
    ** Co says it has cut about 50% of its workforce and
executed a non-binding agreement to license its intellectual
property
    ** Adds that it has secured a bridge loan for $1 mln, which
will extend its cash runway until Q2 2024
    ** Including session's move, stock down ~75.2% YTD

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))